RxDoctor Payments Data

Anjula Chib

Cardiovascular Disease · Dothan, ALNPI 1952807752

Payments from drug & device makers

What this record shows

This record is dominated by grants: $18,000 of the $27,126 with a category attached, or 66.4%. Boston Scientific accounts for 67.8% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $19,587, more than ten times the $121 reported in 2021. Among cardiovascular disease clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,126in general payments, 2019–2025

Across 123 payments — averaging $220.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$18K
  • Biotronik Inc.$4K
  • Medtronic$2K
  • AstraZeneca$411
  • Grifols USA, LLC$254
  • Pfizer$208
  • plus $1K from 12 others

What the payments were for

  • Grants$18,00066%
  • Travel & lodging$4,43816%
  • Food & beverage$4,38416%
  • Education$3051%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,126 in reported general payments places this provider in the 90th percentile of 292 cardiovascular disease providers in Alabama.

See all cardiovascular disease providers in Alabama

Other cardiovascular disease in Dothan

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →